Among 664 DLBCL cases, 170 cases (25.6%) harbored TP53 alterations, comprising 146 cases with solely mutations, 9 with isolated copy number losses (CNLs), and 15 with concurrent mutations and CNLs. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.